Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efstathios Stathopoulos

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Women'S Health|February 8, 2005
Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor statusNikos Tsakountakis, Elias Sanidas, Efstathios Stathopoulos, et al.
Analytical and Quantitative Cytology and Histology|June 29, 2004
Comparison of C-erbB2 (HER-2/Neu) immunohistochemistry results on invasive breast carcinomas. Experience of 2 Pathology departments in Turkey and GreeceOmer Günhan, Maria Kafousi, Bülent Kurt, et al.
American Journal of Clinical Oncology|February 6, 2004
Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myelomaMichael G Alexandrakis, Freda H Passam, Despina S Kyriakou, et al.
Journal of Hematology & Oncology|May 10, 2011
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myelomaAikaterini Sfiridaki, Spiros Miyakis, Constantina Pappa, et al.
Clinical Breast Cancer|June 25, 2014
Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancerKonstantinos Tryfonidis, Maria Kafousi, Maria Perraki, et al.
Leukemia Research|September 24, 2004
Spectral characteristics of acute lymphoblastic leukemia in childhoodNikolaos Katzilakis, Eftichia Stiakaki, Antonios Papadakis, et al.
Anticancer Research|August 21, 2003
E-cadherin expression on fine-needle aspiration biopsies in primary lung adenocarcinomas is related to tumor differentiation and invasionAlexandra Kalogeraki, Demosthenes Bouros, Odysseus Zoras, et al.
Anticancer Research|February 5, 2020
Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung CancerGeorgios Ioannidis, Chara Papadaki, Eleni Lagoudaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancerVassiliki Bozionellou, Dimitris Mavroudis, Maria Perraki, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2009
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation statusAristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Women'S Health|February 8, 2005
Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor statusNikos Tsakountakis, Elias Sanidas, Efstathios Stathopoulos, et al.
Analytical and Quantitative Cytology and Histology|June 29, 2004
Comparison of C-erbB2 (HER-2/Neu) immunohistochemistry results on invasive breast carcinomas. Experience of 2 Pathology departments in Turkey and GreeceOmer Günhan, Maria Kafousi, Bülent Kurt, et al.
American Journal of Clinical Oncology|February 6, 2004
Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myelomaMichael G Alexandrakis, Freda H Passam, Despina S Kyriakou, et al.
Journal of Hematology & Oncology|May 10, 2011
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myelomaAikaterini Sfiridaki, Spiros Miyakis, Constantina Pappa, et al.
Clinical Breast Cancer|June 25, 2014
Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancerKonstantinos Tryfonidis, Maria Kafousi, Maria Perraki, et al.
Leukemia Research|September 24, 2004
Spectral characteristics of acute lymphoblastic leukemia in childhoodNikolaos Katzilakis, Eftichia Stiakaki, Antonios Papadakis, et al.
Anticancer Research|August 21, 2003
E-cadherin expression on fine-needle aspiration biopsies in primary lung adenocarcinomas is related to tumor differentiation and invasionAlexandra Kalogeraki, Demosthenes Bouros, Odysseus Zoras, et al.
Anticancer Research|February 5, 2020
Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung CancerGeorgios Ioannidis, Chara Papadaki, Eleni Lagoudaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancerVassiliki Bozionellou, Dimitris Mavroudis, Maria Perraki, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2009
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation statusAristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki, et al.
Pageof 4